NCT04773561

Brief Summary

It has been known that a pregnant women undergoes significant anatomical and physiological changes that mainly caused by hormonal and hematologic changes during pregnancy. Due to advance in reproductive medicine, the incidence of multifetal pregnancy was increased to 3% of livebirth. Multifetal pregnancies produce much more physiological changes in the body compared to the singleton pregnancies. Physiologic ocular changes during pregnancy are the followings

  • Melanogenesis of eyelid and facial skin
  • Cellular alteration of lacrimal and meibomian gland
  • Increased corneal thickness and corneal curvature
  • Increased lens thickness
  • Increased retinal vascular density
  • Increased choroidal thickness Decreased intraocular pressure -

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
166

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 25, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 26, 2021

Completed
6 months until next milestone

Study Start

First participant enrolled

September 3, 2021

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

September 5, 2021

Status Verified

September 1, 2021

Enrollment Period

2.3 years

First QC Date

February 25, 2021

Last Update Submit

September 2, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Choroidal thickness

    Choroidal thickness was measured by optical coherence tomography.

    30-36 weeks of gestational age

Secondary Outcomes (3)

  • Retinal nerve fiber layer thickness

    30-36 weeks of gestational age

  • Retinal vascular density

    30-36 weeks of gestational age

  • Corneal thickness

    30-36 weeks of gestational age

Study Arms (3)

multifetal pregnancy in the 3rd trimester

EXPERIMENTAL

Corneal tomography, optical coherence tomography and optical coherence tomography angiography were performed in the 3rd trimester, 30-36 weeks of gestational age.

Device: Corneal tomography, optical coherence tomography and optical coherence tomography angiography

singleton pregnancy in the 3rd trimester

ACTIVE COMPARATOR

Corneal tomography, optical coherence tomography and optical coherence tomography angiography were performed in the 3rd trimester, 30-36 weeks of gestational age.

Device: Corneal tomography, optical coherence tomography and optical coherence tomography angiography

age-stratified healthy non-pregnant women

ACTIVE COMPARATOR

Corneal tomography, optical coherence tomography and optical coherence tomography angiography were performed.

Device: Corneal tomography, optical coherence tomography and optical coherence tomography angiography

Interventions

Ocular investigations were performed in one time during 30-36 weeks of gestational age. Due to avoidance of diurnal variation, all examinations were done between 10 am - 12 pm.

age-stratified healthy non-pregnant womenmultifetal pregnancy in the 3rd trimestersingleton pregnancy in the 3rd trimester

Eligibility Criteria

Age24 Years - 37 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years
  • weeks of gestational age
  • clear ocular media
  • written informed consent

You may not qualify if:

  • high risk pregnancies such as pre-eclampsia, gestational diabetic mellitus and asthma
  • history of refractive error, spherical equivalent \> 3 diopters
  • history of retinal diseases such as central serous chorioretinopathy and retinal vascular occlusion
  • history of intraocular inflammation or endophthalmitis
  • history of intraocular laser treatment
  • history of intraocular surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KKU Eye Center, Faculty of Medicine, Khon Kaen University

Phu Wiang, Changwat Khon Kaen, 40002, Thailand

RECRUITING

MeSH Terms

Conditions

Choroidal Effusions

Interventions

Tomography, Optical Coherence

Condition Hierarchy (Ancestors)

Eye AbnormalitiesEye DiseasesChoroid DiseasesUveal Diseases

Intervention Hierarchy (Ancestors)

Tomography, OpticalOptical ImagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisTomographyInvestigative Techniques

Study Officials

  • Suthasinee Sinawat, MD

    KKU Eye Center, Department of Ophthalmology, Faculty of Medicine, Khon Kaen University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Suthasinee Sinawat, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: age-stratified sample technique (2 age groups: 24-30 years and 31-37 years) ,twin pregnancy:singleton pregnancy:healthy non-pregnant women = 1: 2 : 2
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 25, 2021

First Posted

February 26, 2021

Study Start

September 3, 2021

Primary Completion

December 30, 2023

Study Completion

June 30, 2024

Last Updated

September 5, 2021

Record last verified: 2021-09

Locations